Daniel Lin, MD, Urology, Seattle, WA, Seattle Cancer Care Alliance

DanielWeiLinMD

Urology Seattle, WA

Professor of Urology, University of Washington

Overview of Dr. Lin

Dr. Daniel Lin is an urologist in Seattle, WA and is affiliated with multiple hospitals in the area, including Seattle Cancer Care Alliance and University of Washington Medical Center. He received his medical degree from Vanderbilt University School of Medicine and has been in practice 23 years. Dr. Lin accepts several types of health insurance, listed below. He is one of 61 doctors at University of Washington Medical Center and one of 14 doctors at Seattle Cancer Care Alliance who specialize in Urology.

Education & Training

  • Memorial Sloan-KetteringFellowship, Urologic Oncology, 2000 - 2001
  • University of Washington School of MedicineChief Residency, 1998 - 2000
  • University of Washington
    University of WashingtonResidency, Urology, 1994 - 2000
  • University of Washington School of MedicineResidency, 1996 - 1998
  • University of Washington School of MedicineInternship, Surgery, 1994 - 1995
  • Vanderbilt University School of Medicine
    Vanderbilt University School of MedicineClass of 1994
  • Stanford University
    Stanford UniversityB.S, Biology, 1989

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2000 - Present
  • WA State Medical License
    WA State Medical License 1997 - 2022
  • American Board of Urology Urology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2012-2014
  • America's Top Doctors for Cancer Castle Connolly, 2011-2013
  • AUA Leadership Program American Urological Association, 2010
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Testicular Cancer Guidelines.  
    Motzer RJ, Agarwal N, Beard C, Bhayani S, Bolger GB, Buyyounouski MK, Carducci MA, Chang SS, Choueiri TK, Gupta S, Hancock SL, Hudes GR, Jonasch E, Kuzel TM, Lau C, Le..., J Natl Compr Canc Netw 10:502-35
  • Treatment of Metastatic Prostate Cancer – How Urologists should Sequence Available Agents.  
    Mostaghel EA and Lin DW, AUA Update Series
  • Is Pre-diagnosis PSA Velocity Predictive of the Risk of Death from Prostate Cancer Following Radical Prostatectomy?  
    Lin DW and Lange PH, Nature Clinical Practice Urology 1: 66
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • Efficacy of Acucise Incision on Uretero-Enteral Strictures.
    Lin DW, Bush WH, Mayo ME, Northwest Urologic Association, Portland, OR
  • Transurethral Needle Ablation of the Prostate for Treatment of Benign Prostatic Hyperplasia: the University of Washington Experience.
    Lin DW, Ellis WJ, Northwest Urological Society, Seattle, WA
  • Primary Penile Lymphoma Treated With Surgical Excision.
    Lin DW, Krieger JN, Northwest Urological Society, Seattle, WA
  • Join now to see all

Lectures

  • PSA Best Practice Guidelines, Update on Cancer-Related AUA Guidelines: Preparation for Recertification. 
    Multiple locations, 2008
  • The Role of Peri-Operative Chemotherapy in High-Risk Prostate Cancer: PUNCH and VA Surgical Trials. 
    3rd Annual John R. Murren Oncology Symposium, Las Vegas, NV
  • Progress and Promise in Prostate Cancer. 
    Albany VA Grand Rounds, Albany, NY
  • Join now to see all

Press Mentions

  • Prostate Cancer Guidelines Lack Molecular Test Recommendations
    Prostate Cancer Guidelines Lack Molecular Test RecommendationsOctober 24, 2020 18:55
  • SCCA’s Immunotherapy Leaders Featured at the American Society of Clinical Oncology (ASCO) Annual Meeting
    SCCA’s Immunotherapy Leaders Featured at the American Society of Clinical Oncology (ASCO) Annual MeetingMay 31, 2019 00:43
  • Use of Novel Hormonal Agents and Systemic Therapy in Advanced Prostate Cancer Highlights (2018)
    Use of Novel Hormonal Agents and Systemic Therapy in Advanced Prostate Cancer Highlights (2018)December 01, 2018 17:08
  • Join now to see all

Grant Support

  • In Vivo Effects Of Sulforaphane Supplementation On Normal Human ProstateNational Cancer Institute2009–2011
  • In Vivo Molecular Effects Of Prostatic COX-2 InhibitionNational Institute Of Diabetes And Digestive And Kidney Diseases2003–2007

Committees

  • Member, Castration-resistant Prostate Cancer Guidelines Panel, AUA 2015 - Present

Professional Memberships

Hospital Affiliations

Insurance Accepted

  • Aetna Choice POS II
    BCBS Blue Card PPO
    BCBS Illinois PPO
    BCBS Texas BlueChoice
    CIGNA HMO
    CIGNA Open Access
    CIGNA PPO
    First Choice
    First Health PPO
    Great West PPO
    Health Net Oregon PPO
    Humana ChoiceCare Network PPO
    Multiplan PPO
    ODS Network
    Premera BCBS Heritage & Heritage Plus 1
    Providence Health System Personal Option
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
  • Please verify your coverage with the provider's office directly when scheduling an appointment